scoping study ... when will we see it???, page-9

Dear Todays really we don't have to sell, well not at 28 cents. At that price we should not sell.
There is also no buyer without something to buy.
Maybe a simple note to this Chinese outfit explaining we can't continue talks based upon the current offer. Reasons being current resource size, expected expansion of resource size the scoping study and price of Antimony. Indicating clearly that at this price the sale of AHR.AX is not in the interests of EVEN ONE share holder.
Second buyer would be nice a little tension in the market can lead to more robust negotiations.
Either way along with you would like to be a fly on the wall watching the progress.
In the end a little of the 'Abbott stare' should come into play when FUTURE offers below 65 cents are made.